test

Scott Smith

@Acuta Capital Partners, Llc

Latest period2024 - Q3ReportedManaged Assets$123.464MTotal holdings41
Assets growth rate3.99%Assets growth rate (2-Q avg)-9.44%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Acuta Capital Partners, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 41 positions.

Assets under management

The assets under management (AUM) of Acuta Capital Partners, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 123.464M in assets, with a quarterly growth rate of 3.99% and a 2-quarter average growth rate of -9.44%. The portfolio is managed by Scott Smith, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ARTVArtiva Biotherapeutics Inc
Recent Activity
New Position
0.56%
$679,800
44,000 shares@ $15.45 avg price
TECXTectonic Therapeutic Inc
Recent Activity
New Position
0.34%
$415,110
13,700 shares@ $30.3 avg price
CLYMClimb Bio Inc
Recent Activity
New Position
0.23%
$274,860
54,000 shares@ $5.09 avg price
BNTCBenitec Biopharma Inc
Recent Activity
New Position
0.23%
$273,862
29,800 shares@ $9.19 avg price
TVTXTravere Therapeutics Inc
Recent Activity
New Position
0.22%
$265,810
19,000 shares@ $13.99 avg price
THRDThird Harmonic Bio Inc
Recent Activity
New Position
0.18%
$210,133
15,508 shares@ $13.55 avg price